Immunovant Inc
NASDAQ:IMVT
Immunovant Inc
NASDAQ:IMVT
Price:
25.75
USD
0.43%
Market Closed
Market Cap:
$5.2B
Balance Sheet
Balance Sheet Decomposition
Immunovant Inc
Immunovant Inc
Balance Sheet Decomposition is not available for
Immunovant Inc
Immunovant Inc
Balance Sheet
Immunovant Inc
Immunovant Inc
Currency: USD
| Dec-2018 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
101
|
400
|
494
|
377
|
635
|
714
|
|
| Cash |
0
|
101
|
400
|
494
|
377
|
635
|
714
|
|
| Total Receivables |
0
|
3
|
1
|
13
|
1
|
6
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
12
|
1
|
5
|
2
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
6
|
8
|
6
|
27
|
25
|
51
|
|
| Total Current Assets |
0
|
109
|
409
|
513
|
404
|
666
|
768
|
|
| PP&E Net |
0
|
0
|
4
|
3
|
2
|
1
|
1
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
8
|
|
| Total Assets |
0
N/A
|
109
+27 250%
|
413
+277%
|
516
+25%
|
406
-21%
|
666
+64%
|
776
+16%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
1
|
2
|
19
|
1
|
7
|
18
|
|
| Accrued Liabilities |
0
|
11
|
16
|
26
|
42
|
41
|
51
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
3
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
15
|
19
|
45
|
43
|
49
|
69
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
2
|
1
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
15
+3 725%
|
21
+37%
|
46
+118%
|
43
-5%
|
49
+12%
|
69
+41%
|
|
| Equity | ||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
0
|
91
|
199
|
355
|
566
|
826
|
1 240
|
|
| Additional Paid In Capital |
0
|
185
|
590
|
825
|
928
|
1 442
|
1 945
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
2
|
1
|
|
| Total Equity |
0
N/A
|
94
N/A
|
392
+316%
|
470
+20%
|
363
-23%
|
618
+70%
|
707
+15%
|
|
| Total Liabilities & Equity |
0
N/A
|
109
+27 250%
|
413
+277%
|
516
+25%
|
406
-21%
|
666
+64%
|
776
+16%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
13
|
57
|
98
|
117
|
130
|
146
|
170
|
|
Switch to:
Switch to:
See Also
Discover More
